MENU
149th Global

Antoni Torres

UNIV BARCELONA
Barcelona / España
149th Global

Mentions data

Menciones por sus áreas de investigación
Clinical Medicine
  •   Twitter
  • 3.5K
  •   Wikipedia
  • 2
  •   News
  • 26
  •   Policy
  • 7
Immunology
  •   Twitter
  • 802
  •   Wikipedia
  • 2
  •   News
  • 48
  •   Policy
  • 3
Microbiology
  •   Twitter
  • 290
  •   Wikipedia
  • 3
  •   News
  • 24
  •   Policy
  • 1
Pharmacology & Toxicology
  •   Twitter
  • 198
  •   Wikipedia
  • 2
  •   News
  • 12
  •   Policy
  • 3

Mentions Chart

Influratio by dimension
  • Twitter
  • Wikipedia
  • News
  • Policy
PERSONA MENTIONS
  •   Twitter
  • 9.2K
  •   Wikipedia
  • 15
  •   News
  • 184
  •   Policy
  • 27

Trabajos con más influratio

Mentions   0   Wikipedia   1   News   2   Policy
Article International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia Torres, A; Niederman, MS; Chastre, J; Ewig, S; Fernandez-Vandellos, P; Hanberger, H; Kollef, M; Bassi, GL; Luna, CM; Martin-Loeches, I; Paiva, JA; Read, RC; Rigau, D; Timsit, JF; Welte, T; Wunderink, R EUROPEAN RESPIRATORY JOURNAL 0903-1936 (2017) DOI / 10.1183/13993003.00582-2017 OPEN ACCESS LEVEL / Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Biomarkers in the ICU: less is more? No Torres, A; Artigas, A; Ferrer, R INTENSIVE CARE MEDICINE 0342-4642 (2021) DOI / 10.1007/s00134-020-06271-4 OPEN ACCESS LEVEL / Green Published, Bronze
Mentions   0   Wikipedia   17   News   0   Policy
Letter Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection Bermejo-Martin, JF; Almansa, R; Menendez, R; Mendez, R; Kelvin, DJ; Torres, A JOURNAL OF INFECTION 0163-4453 (2020) DOI / 10.1016/j.jinf.2020.02.029 OPEN ACCESS LEVEL / Green Published
Mentions   0   Wikipedia   3   News   2   Policy
Article Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial Torres, A; Zhong, NS; Pachl, J; Timsit, JF; Kollef, M; Chen, ZJ; Song, J; Taylor, D; Laud, PJ; Stone, GG; Chow, JW LANCET INFECTIOUS DISEASES 1473-3099 (2018) DOI / 10.1016/s1473-3099(17)30747-8 OPEN ACCESS LEVEL / Green Accepted
Mentions   1   Wikipedia   9   News   0   Policy
Article A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Path Huang, DB; O'Riordan, W; Overcash, JS; Heller, B; Amin, F; File, TM; Wilcox, MH; Torres, A; Dryden, M; Holland, TL; McLeroth, P; Shukla, R; Corey, GR CLINICAL INFECTIOUS DISEASES 1058-4838 (2018) DOI / 10.1093/cid/cix987 OPEN ACCESS LEVEL / Bronze, Green Published
Mentions   0   Wikipedia   10   News   0   Policy
Article Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections Huang, DB; Corey, GR; Holland, TL; Lodise, T; O'Riordan, W; Wilcox, MH; File, TM; Dryden, M; Balser, B; Desplats, E; Torres, A INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 0924-8579 (2018) DOI / 10.1016/j.ijantimicag.2018.05.012 OPEN ACCESS LEVEL / NA
Mentions   0   Wikipedia   10   News   0   Policy
Article Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections Huang, DB; Corey, GR; Holland, TL; Lodise, T; O'Riordan, W; Wilcox, MH; File, TM; Dryden, M; Balser, B; Desplats, E; Torres, A INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 0924-8579 (2018) DOI / 10.1016/j.ijantimicag.2018.05.012 OPEN ACCESS LEVEL / NA
Mentions   0   Wikipedia   0   News   0   Policy
Review Systematic review and meta-analysis of the safety of erythromycin compared to clarithromycin in adults and adolescents with pneumonia Eljaaly, K; Botaish, A; Bahobail, F; Almehmadi, M; Assabban, Z; Thabit, AK; Alraddadi, B; Aljabri, A; Alqahtani, N; Aseeri, MA; Hashim, A; Torres, A JOURNAL OF CHEMOTHERAPY 1120-009X (2020) DOI / 10.1080/1120009x.2019.1680116 OPEN ACCESS LEVEL / NA
Among researchers in Clinical Medicine
Among researchers in Immunology
Among researchers in Microbiology
Among researchers in Pharmacology & Toxicology
PROYECTO FINANCIADO POR PLAN NACIONAL DE INVESTIGACIÓN AGENCIA ESTATAL DE INVESTIGACIÓN, MINISTERIO DE CIENCIA E INNOVACIÓN. PID2019-109127RB-I00